Our therapy areas

Pioneering T cell receptor innovation

Immunocore is a leading T Cell Receptor (TCR) biotechnology company focused on delivering first-in-class biological therapies that will have the potential to address unmet needs in cancer, infectious and autoimmune diseases.

Immunocore has a robust clinical-stage pipeline of wholly-owned and partnered programmes across three different therapeutic areas:


Molecules in development

ImmTAC (Immune Mobilizing Monoclonal TCRs Against Cancer) molecules

Infectious Diseases

Molecules in development

ImmTAV and ImmTAB (Immune Mobilizing Monoclonal TCRs Against Virus or Bacteria) molecule

Autoimmune and Inflammation diseases

Molecules in development

ImmTAAI (Immune Mobilizing Monoclonal TCRs Against Autoimmune Disease) molecule